to evaluate whether long-term human fetal exposure to beta 2-adrenergic receptor agonists elicit alterations in the human fetal heart , a fetal echocardiographic examination was performed in 9 fetuses between the 24th and 35th week of gestation ( median 28 weeks ) and 9 age-matched controls .
C0015935
fetal heart
C0015965
fetuses